Children’s Robitussin and Dimetapp Cough Medicines Recalled Due to Potential Overdose Risks

Children’s Robitussin and Dimetapp Cough Medicines Recalled Due to Potential Overdose Risks
Toddler's Dimetapp cold and cough medicine is seen at a Rite Aid store, on August 15, 2007 in San Francisco, California. David Paul Morris/Getty Images
|Updated:

Parents take note: GlaxoSmithKline Consumer Healthcare has voluntarily recalled three lots of its children’s cough syrups—Children’s Robitussin Honey Cough and Chest Congestion DM and Children’s Dimetapp Cold and Cough—due to the products having incorrect dosing cups in their packaging.

That means parents might accidentally overdose a child by putting too much syrup in the cup.